High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: Correlation with positron-emission tomography and histopathologic findings

American Journal of Neuroradiology

Volumn 28, Issue 7, 2007, Pages 1280-1286

  Pinker, K ^a   Noebauer Huhmann, I M ^a   Stavrou, I ^a   Hoeftberger, R ^b   Szomolanyi, P ^a   Karanikas, G ^a   Weber, M ^a   Stadlbauer, A ^c   Knosp, E ^a   Friedrich, K ^a   Trattnig, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE; METHIONINE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; EPENDYMOMA; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; SIGNAL NOISE RATIO; STATISTICAL ANALYSIS; TUMOR VASCULARIZATION;

ADULT; AGED; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS;

EID: 34548179799     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A0540     Document Type: Article

References (32)

1. Barth M, Nobauer-Huhmann IM, Reichenbach JR, et al. High-resolution three-dimensional contrast-enhanced blood oxygenation level-dependent magnetic resonance venography of brain tumors at 3 Tesla: first clinical experience and comparison with 1.5 Tesla. Invest Radiol 2003;38:409-14
2. Rauscher A, Sedlacik J, Barth M, et al. Magnetic susceptibility- weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005;26:736-42
3. Rauscher A, Sedlacik I, Fitzek C, et al. High resolution susceptibility weighted MR-imaging of brain tumors during the application of a gaseous agent. Rofo 2005;177:1065-69
4. Reichenbach JR, Barth M, Haacke EM, et al. High-resolution MR venography at 3.0 Tesla. J Comput Assist Tomogr 2000;24:949-57
5. Reichenbach JR, Essig M, Haacke EM, et al. High-resolution venography of the brain using magnetic resonance imaging. Magma 1998;6:62-69
6. Reichenbach JR, Haacke EM. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed 2001;14:453-67
7. Reichenbach JR, Jonetz-Mentzel L, Fitzek C, et al. High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique. Neuroradiology 2001;43:364-69
8. Reichenbach JR, Venkatesan R, Schillinger DJ, et al. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204:272-77
9. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612-18
10. Haddar D, Haacke E, Sehgal V, et al. Susceptibility weighted imaging. Theory and applications [in French]. J Radiol 2004;85:1901-08
11. Lin W, Mukherjee P, An H, et al. Improving high-resolution MR bold venographic imaging using a T1 reducing contrast agent. J Magn Reson Imaging 1999;10:118-23
12. Noebauer-Huhmann IM, Pinker K, Barth M, et al. Contrast-enhanced, high-resolution, susceptibility-weighted magnetic resonance imaging of the brain: dose-dependent optimization at 3 Tesla and 1.5 Tesla in healthy volunteers. Invest Radiol 2006;41:249-55
13. Thong K. Susceptibility-weighted imaging (SWI) case reports. Magnetom Flash 2006;32:70-73
14. Tynninen O, Aronen HJ, Ruhala M, et al. MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation. Invest Radiol 1999;34:427-34
15. Robinson SP, Howe FA, Rodrigues LM, et al. Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow. Semin Radiat Oncol 1998;8:197-207
16. Bagley LJ, Grossman RI, Judy KD, et al. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology 1997;202:511-16
17. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215-29
18. Butowski NA, Sneed PK, Chang SM. Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol 2006;24:1273-80
19. Hsieh JC, Lesniak MS. Surgical management of high-grade gliomas. Expert Rev Neurother 2005;5:S33-S39
20. Schramm J, Blumcke I, Ostertag CB, et al. Low-grade gliomas - current concepts. Zentralbl Neurochir 2006;67:55-66
21. Stieber VW. Low-grade gliomas. Curr Treat Options Oncol 2001;2:495-506
22. Burger PC, Vogel FS, Green SB, et al. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 1985;56:1106-11
23. Schad LR. Improved target volume characterization in stereotactic treatment planning of brain lesions by using high-resolution BOLD MR-venography. NMR Biomed 2001;14:478-83
24. Christoforidis GA, Grecula JC, Newton HB, et al. Visualization of microvascularity in glioblastoma multiforme with 8-T high-spatial-resolution MR imaging. AJNR Am J Neuroradiol 2002;23:1553-56
25. Trattnig S, Pinker K, Ba-Ssalamah A, et al. The optimal use of contrast agents at high field MRI. Eur Radiol 2006;16:1280-87
26. Christoforidis GA, Kangarlu A, Abduljalil AM, et al. Susceptibility- based imaging of glioblastoma microvascularity at 8 T: correlation of MR imaging and postmortem pathology. AJNR Am J Neuroradiol 2004;25:756-60
27. Ba-Ssalamah A, Nobauer-Huhmann IM, Pinker K, et al. Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases. Invest Radiol 2003;38:415-22
28. Sehgal V, Delproposto Z, Haddar D, et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 2006;24:41-51
29. Stadlbauer A, Gruber S, Nimsky C, et al. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 2006;238:958-69
30. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44:656-66
31. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989-98
32. Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005;22:439-50